The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population.
Vear, Susan I; Ayers, Gregory D; Van Driest, Sara L; Sidonio, Robert F; Stein, Charles Michael; Ho, Richard H.
Br J Haematol
; 165(6): 832-5, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24601977
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects.
Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey.
Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool.
Estimation of the warfarin dose with clinical and pharmacogenetic data.
Nutri-pharmacogenomics of warfarin anticoagulation therapy: VKORC1 genotype-dependent influence of dietary vitamin K intake.
Methods for Predicting Warfarin Dose Requirements.
[Influence of genetic polymorphisms and non-genetic factors on the maintenance dose of warfarin].
Value of VKORC1 (-1639G>A) rs9923231 genotyping in predicting warfarin dose: A replication study in South Indian population.
A pharmacogenetic versus a clinical algorithm for warfarin dosing.